Lpl Financial LLC Infinity Pharmaceuticals, Inc. Transaction History

Lpl Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.49 - $1.2 $20,368 - $49,881	-41,568 Reduced 25.99%	118,388 $75,000
Q1 2022 May 16, 2022	BUY	$0.85 - $2.4 $17,513 - $49,449	20,604 Added 14.79%	159,956 $182,000
Q4 2021 Feb 14, 2022	SELL	$1.86 - $3.36 $56,558 - $102,170	-30,408 Reduced 17.91%	139,352 $314,000
Q3 2021 Nov 15, 2021	BUY	$1.52 - $3.82 $258,035 - $648,483	169,760 New	169,760 $581,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.